MDMA-Assisted Therapy Cuts PTSD Symptoms but FDA Still Says No
Phase 3 trial data showing 67% of MDMA-treated PTSD patients lost their diagnosis has pushed psychedelic research into mainstream medicine, even as federal regulators rejected the first formal…
